Cargando…
Targeting surface-layer proteins with single-domain antibodies: a potential therapeutic approach against Clostridium difficile-associated disease
Clostridium difficile is a leading cause of death from gastrointestinal infections in North America. Antibiotic therapy is effective, but the high incidence of relapse and the rise in hypervirulent strains warrant the search for novel treatments. Surface layer proteins (SLPs) cover the entire C. dif...
Autores principales: | Kandalaft, Hiba, Hussack, Greg, Aubry, Annie, van Faassen, Henk, Guan, Yonghong, Arbabi-Ghahroudi, Mehdi, MacKenzie, Roger, Logan, Susan M., Tanha, Jamshid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768215/ https://www.ncbi.nlm.nih.gov/pubmed/25936376 http://dx.doi.org/10.1007/s00253-015-6594-1 |
Ejemplares similares
-
Isolation and characterization of a VHH targeting the Acinetobacter baumannii cell surface protein CsuA/B
por: Lei, Eric K., et al.
Publicado: (2023) -
Design and characterization of a novel lytic protein against Clostridium difficile
por: Wang, Meng, et al.
Publicado: (2022) -
Expression and delivery of an endolysin to combat Clostridium perfringens
por: Gervasi, Teresa, et al.
Publicado: (2013) -
Neutralization of Clostridium difficile toxin B with V(H)H-Fc fusions targeting the delivery and CROPs domains
por: Hussack, Greg, et al.
Publicado: (2018) -
An update on antibody-based immunotherapies for Clostridium difficile infection
por: Hussack, Greg, et al.
Publicado: (2016)